---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-133252"
form_type: "8-K"
ticker: "VNDA"
cik: "0001347178"
company_name: "Vanda Pharmaceuticals Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T17:00:14.508247+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vanda receives revised unsolicited takeover proposal from Future Pak at $7.25-$7.75/share plus CVRs

## Summary
- Revised proposal of $7.25-$7.75 per share in cash plus Contingent Value Rights (CVRs).
- Vanda's Board will evaluate the proposal with its financial and legal advisors.
- Prior proposal at same price range was rejected by Vanda.
- No shareholder action required at this time.

## SEC filing metadata
- accession: 0001193125-24-133252
- form_type: 8-K
- ticker: VNDA
- cik: 0001347178
- company_name: Vanda Pharmaceuticals Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347178/000119312524133252/0001193125-24-133252-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347178/000119312524133252/d810702d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-133252
- JSON: https://secwatch.observer/filing/0001193125-24-133252.json
- Plain text: https://secwatch.observer/filing/0001193125-24-133252.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.